Ahead Health raises €8.7M to bring preventive check-ups from Switzerland into Germany and the Netherlands

Ahead Health (Zürich) has raised €8.7 million / $10 million co-led by 3VC and RTP Global. RTP Global had led the company's previous round — a €5.1 million ($6 million) raise in January 2026 — and returns here as co-lead alongside 3VC, which is entering as a new investor. The company was founded in 2024 by Nick Lenten (CEO) and a team of ex-Google executives, medical doctors, and healthtech builders. The raise accompanies a geographic expansion: Ahead Health is now live in Germany, starting in Munich, with a waitlist open in the Netherlands.

What Ahead Health does

Ahead Health is a preventive health platform built around a single design principle: that meaningful early detection requires combining multiple data sources into one coherent picture, reviewed by a doctor, in a format that fits a normal schedule. Its check-up combines advanced blood panels and whole-body MRI, both completed in 30 minutes, with the results translated by an AI-powered platform into a personalised health plan and reviewed by a licensed physician before delivery.

The platform is designed for repeat use, not one-off snapshots. Each subsequent check-up compares against the individual's own baseline, tracking change over time rather than against population averages — which the company argues allows meaningful signals to surface earlier. The claimed detection range covers metabolic health, inflammation markers, organ function, cardiovascular risk, and conditions including cancer, brain disease, endometriosis, and cardiovascular disease — at a stage that traditional healthcare, oriented around acute symptoms rather than pre-symptomatic signals, typically would not yet identify.

Since launching in Switzerland, Ahead Health has built a network of more than 20 partner centres. The expansion model is asset-light: instead of building its own facilities, the company partners with established local clinics, radiology centres, and doctors. In Germany and the Netherlands, it is rolling out through existing medical infrastructure rather than competing with it.

Into Germany and the Netherlands

The capital funds the first stage of European expansion. In Germany, check-ups are now bookable in Munich, with the initial rollout focused on a comprehensive blood test — mapping metabolic health, inflammation markers, organ function, and cardiovascular risk, with every result reviewed by a licensed doctor and accompanied by a personal action plan. Imaging, including MRI, is planned to follow. In the Netherlands, a waitlist is open and the full launch is targeted for August.

"We back only a handful of teams each year, looking for founders tackling the world's most essential causes," said Peter Lasinger, Partner at 3VC. "Ahead Health stands out because they combine a deeply mission-driven culture, with absolute rigour and deep technical excellence. They're not just building a platform, they are transforming healthcare from the ground up. We're incredibly proud to support this world-class team as they expand into Germany and the Netherlands."

The company's community of patients and clinical partners in Switzerland forms both the evidence base and the distribution anchor for the expansion: the same network that proved the model in a single market now provides the template and the word-of-mouth that new markets run on.